The Latest Cardiac and Vascular News
Kosmos Platform Will Now Offer Physicians Accurate Heart Health Analysis in Minutes REDMOND, Wash.–(BUSINESS WIRE)–EchoNous, the leader in ultra-portable, AI-guided point-of-care ultrasound (POCUS) tools and software, announced that the company has partnered with Singapore-based Us2.ai, developers of machine learning-driven software that automates the analyses of echocardiographic imagery and measurements. Us2.ai’s […]
LOS ANGELES, Aug. 4, 2021 /PRNewswire/ — Today, Abcentra LLC announced that the first patients have been dosed in its multi-center phase 2 trial assessing the safety and activity of orticumab in patients with moderate-to-severe plaque psoriasis and cardiometabolic risk factors. Orticumab is a fully-human monoclonal antibody against a specific oxidized low-density lipoprotein (LDL) epitope. Seventeen […]
Findings could potentially widen use for overweight adults who are high risk for heart disease CLEVELAND – A clinical trial led by Dr. Ian Neeland with University Hospitals Harrington Heart & Vascular Institute could have implications for overweight and obese adults who may benefit from reducing intra-abdominal fat. The […]
Significant Superficial Arm Vein Dilation Reported with the FA-1 Device LOS ALTOS HILLS, Calif.–(BUSINESS WIRE)–Fist Assist Devices, LLC, announces completion of the non-significant risk FACT Trial (Fist Assist Clinical Trial). FACT evaluated the use of an intermittent pneumatic compression device, model FA-1, that was developed by Fist Assist Devices, to […]
Study is first to compare interventional therapy in combination with anticoagulation to anticoagulation alone for treatment of pulmonary embolism MARLBOROUGH, Mass., Aug. 4, 2021 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) has commenced enrollment in the HI-PEITHO clinical trial, a collaborative research study with the Pulmonary Embolism Response Team (PERT) Consortium and the […]
WEBSTER, Texas, Aug. 4, 2021 /PRNewswire/ — Corvion – developer of fully implanted mechanical circulatory support devices – announced today that William Cohn, MD and Sean Morris have been appointed to the company’s Board of Directors, effective immediately. Dr. Cohn currently serves as Vice President for Johnson & Johnson Medical Devices Companies and the Executive […]
Total revenue increased 23% to $12.0 million. Core non-COVID-19 product sales increased 38% Y-Y, driving overall Q2 2021 product sales to $11.4 million versus $9.5 million a year ago MONMOUTH JUNCTION, N.J., Aug. 3, 2021 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery […]
Funding Will Support the Company’s First Clinical Trial on its Path to Regulatory Clearance OR YEHUDA, Israel, Aug. 4, 2021 /PRNewswire/ — Append Medical, developer of the first no-implant minimally invasive solution for transcatheter Left Atrial Appendage (LAA) exclusion, today announced the completion of a $7.4 million Series A financing round. The round will enable Append […]
– Ultreon™ 1.0 Software, the first-of-its-kind imaging software, merges optical coherence tomography with the power of automation using Artificial Intelligence – The new intuitive interface provides step-by-step guidance to enhance ease of use – When combined with Abbott’s Dragonfly OpStar™ imaging catheter and PressureWire X™, the platform provides physicians with […]
LAGUNA HILLS, Calif., Aug. 3, 2021 /PRNewswire/ — Adagio Medical, Inc., a leading innovator in catheter ablation technologies for atrial fibrillation (AF) and ventricular tachycardia (VT), announced the results of its CryoCure-2 ultra-low temperature cryoablation (ULTC) prospective multi-center study in patients with AF at the 2021 Heart Rhythm Society Annual Meeting. The late-breaking […]
